XQ is the Founder and Managing Partner of EVX Ventures. He is a synergistic business partner to entrepreneurial scientists/innovators, with a track record in taking technologies from concept to commercial reality.
Elan Ezickson joined the board in 2019. He brings his extensive strategic, biopharmaceutical, operational, and capital formation expertise to Carmine Therapeutics.
Professor Lodish is a Founding Member of the Whitehead Institute for Biomedical Research. He is a Professor of Biology and a Professor of Biological Engineering at the Massachusetts Institute of Technology (MIT).
Professor Lodish is a Founding Member of the Whitehead Institute for Biomedical Research. He is a Professor of Biology and a Professor of Biological Engineering at the Massachusetts Institute of Technology (MIT).
Dr. Mark Kay is an acknowledged leader in the field of gene therapy and is a leading researcher in both viral and non-viral gene transfer vector systems.
Dr. Minh Le is presently an Assistant Professor and the Graduate Program Director at the Department of Pharmacology at the National University of Singapore.
Jianzhu Chen is a Professor of Biology at the Koch Institute for Integrative Cancer Research and at the Massachusetts Institute of Technology Department of Biology.
Tenzin is an Associate at EVX Ventures and a founding member of Carmine Therapeutics. He obtained his Ph.D. in Molecular Pharmacology from New York University Medical Center.
